Ching-Hwa Sung, PhD

The Betty Neuwirth Lee and Chilly Professor in Stem Cell Research

Contact & profiles

Appointments

Professor of Cell Biology in OphthalmologyPrimary
Ophthalmology · 2006–
Professor of Cell Biology in Neuroscience
Brain and Mind Research · 2024–
The Betty Neuwirth Lee and Chilly Professor in Stem Cell Research
Ophthalmology · 2017–
Professor
Weill Cornell Graduate School — Neuroscience · 1995–

Past Appointments

Professor of Cell and Developmental Biology
Cell and Developmental Biology · 2006–2025
Associate Professor of Cell Biology in Ophthalmology
Ophthalmology · 2000–2006
Associate Professor of Cell and Developmental Biology
Cell and Developmental Biology · 2000–2006

Show all 5

Assistant Professor of Cell Biology and Anatomy
Cell and Developmental Biology · 1994–2000
Assistant Professor of Cell Biology in Ophthalmology
Ophthalmology · 1994–2000

Education

Highlights

1
Nature communications · 2022
JCJen-Zen ChuangANAfnan NuruzzamanCSChing-Hwa Sung
PMID: 35042858PMCID: PMC8766482DOISenior author41 citations
2
Nature communications · 2024
JCJen-Zen Chuang NSNeeta S Roy CSChing-Hwa Sung
PMID: 39043666PMCID: PMC11266608DOISenior author9 citations
3
Bio-protocol · 2018
CSChing-Hwa Sung
PMID: 34179289PMCID: PMC8203858DOISenior author

3 grants

PI
Preliminary study of exosome treatment in an acute dry age-related macular degeneration (AMD) mouse model
3D Global Biotech INC · 2026–2028Contract
SRA 261588-01
PI
Endosome regulated retinal homeostasis and disease
National Eye Institute · 2018–2027· 2 renewals
R01EY029428-08
PI
Modeling and mechanistic investigation of a novel dry AMD mouse model with CLIC4 deleted in RPE
National Eye Institute · 2021–2026
R01EY032966-04

Completed grants (6)

PI
Making cone-rich retinas in dishes by manipulating ciliary dynamics and cell division
Alcon Laboratories, Inc. · 2017–2021
ARI 180814-03
PI
Control of Retinal Neurogenesis by Cilium-Mediated Cell Cycle Progression and Cell Fate Choice
Research to Prevent Blindness, Inc. · 2016–2019
RPB 17020218-03
PI
Strategy and Development of New Drug Development and Macular Degeneration Treatment for Macular Diseases with High Throughput Screening Drug System
Kaohsiung Medical University · 2018–2019Contract
SRA 183224-01
PI
Structural and Functional Integrity and Microenvironment of RPE Cells
National Eye Institute · 2012–2017
R01EY016805-09 EW
PI
Molecular Basis of Protein Transport in Photoreceptor
National Eye Institute · 2011–2016
R01EY011307-20 EW
MPI
MODULE--TISSUE AND CELL CULTURE
NEI · 2005–2010 · via NIH RePORTER
R24EY015656-05

Preclinical Model Offers New Insights into Parkinson’s Disease Process
July 23, 2024
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease in people, according to a study led by Weill Cornell Medicine researchers.
Pre-Clinical Model May Enable Development of New Treatments for Leading Cause of Age-Related Vision Loss
January 18, 2022
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, called dry age-related macular degeneration (dry AMD), and used it to identify new treatment modalities and drug targets.